主要文件

查看所有文档

T27855

2-噻吩乙醇

Name: 2-噻吩乙醇
Brand: ALDRICH

98%

别名:

2-(2-噻吩基)乙醇, 2-(2-羟乙基)噻吩

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₆H₈OS

化学文摘社编号:

5402-55-1

分子量:

128.19

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24900076

EC Number:

226-452-0

Beilstein/REAXYS Number:

106985

MDL number:

MFCD00005462

Assay:

98%

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

98%

refractive index

n20/D 1.551 (lit.)

bp

108-109 °C/13 mmHg (lit.)

density

1.153 g/mL at 25 °C (lit.)

SMILES string

OCCc1cccs1

InChI

1S/C6H8OS/c7-4-3-6-2-1-5-8-6/h1-2,5,7H,3-4H2

InChI key

VMJOFTHFJMLIKL-UHFFFAOYSA-N

说明

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

221.0 °F - closed cup

flash_point_c

105 °C - closed cup

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.

Radoslaw Laufer et al.

Bioorganic & medicinal chemistry, 22(17), 4968-4997 (2014-07-22)

TTK kinase was identified by in-house siRNA screen and pursued as a tractable, novel target for cancer treatment. A screening campaign and systematic optimization, supported by computer modeling led to an indazole core with key sulfamoylphenyl and acetamido moieties at

全球贸易项目编号

货号	GTIN
T27855-25G	04061833052709
T27855-100G	04061833052693
T27855-5G	04061833052716